Keeping NDA On Schedule After Unexpected FDA Feedback

With just months left until planned submission of a new drug application (NDA), the Food and Drug Administration mandated 5 unexpected supplemental studies for a new oncology drug. Worldwide is experienced in the common FDA-required studies for NDA submission and responded quickly. The NDA was able to be submitted on schedule and received approval.